Vaccination of stem cell transplant recipients:: recommendations of the Infectious Diseases Working Party of the EBMT

被引：166

作者：

Ljungman, P ^{[1
]}

Engelhard, D ^{[1
]}

de la Cámara, R ^{[1
]}

Einsele, H ^{[1
]}

Locasciulli, A ^{[1
]}

Martino, R ^{[1
]}

Ribaud, P ^{[1
]}

Ward, K ^{[1
]}

Cordonnier, C ^{[1
]}

机构：

[1] Karolinska Univ Hosp Huddinge, Dept Hematol, SE-14186 Stockholm, Sweden

来源：

BONE MARROW TRANSPLANTATION | 2005年 / 35卷 / 08期

关键词：

vaccination; recommendations; infections;

D O I：

10.1038/sj.bmt.1704870

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Over the last 25 years, the numbers of hematopoietic stem cell transplant ( SCT) patients have increased rapidly. Infections have been major obstacles for successful transplantation. Thus, infection prevention is very important in transplant recipients. As the results of transplantation have improved, the number of long- term survivors has increased. Vaccination is a potentially important strategy for reducing the risk for vaccine-preventable infections after SCT. The EBMT produced recommendations for vaccination of SCT recipients published in Bone Marrow Transplantation in 1995. This paper updates the previous recommendations based on current knowledge.

引用

页码：737 / 746

页数：10

共 52 条

[31] Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation
Molrine, DC
Guinan, EC
Antin, JH
Parsons, SK
Weinstein, HJ
Wheeler, C
McGarigle, C
Blanding, P
Phillips, NR
Kinsella, K
Deans, K
Ciamarra, A
Goorin, A
George, S
Ambrosino, DM
[J]. BLOOD, 1996, 87 (07) : 3012 - 3018
[32] Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
Molrine, DC
Antin, JH
Guinan, EC
Soiffer, RJ
MacDonald, K
Malley, R
Malinoski, F
Trocciola, S
Wilson, M
Ambrosino, DM
[J]. BLOOD, 2003, 101 (03) : 831 - 836
[33] Molrine DC, 1996, BONE MARROW TRANSPL, V17, P1149
[34] Nakano T, 1996, ACTA PAEDIATR JAPON, V38, P212
[35] Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines
Nordoy, T
Husebekk, A
Aaberge, IS
Jenum, PA
Samdal, HH
Flugsrud, LB
Kristoffersen, AC
Holte, H
Kvaloy, S
Kolstad, A
[J]. BONE MARROW TRANSPLANTATION, 2001, 28 (07) : 681 - 687
[36] IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines
Parkkali, T
Käyhty, H
Antilla, M
Ruutu, T
Wuorimaa, T
Soininen, A
Volin, L
Ruutu, P
[J]. BONE MARROW TRANSPLANTATION, 1999, 24 (06) : 671 - 678
[37] Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT
Parkkali, T
Stenvik, M
Ruutu, T
Hovi, T
Volin, L
Ruutu, P
[J]. BONE MARROW TRANSPLANTATION, 1997, 20 (08) : 663 - 668
[38] A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT
Parkkali, T
Olander, RM
Ruutu, T
Vuontela, K
Volin, L
Eskola, J
Ruutu, P
[J]. BONE MARROW TRANSPLANTATION, 1997, 19 (09) : 933 - 938
[39] Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients
Parkkali, T
Käyhty, H
Lehtonen, H
Ruutu, T
Volin, L
Eskola, J
Ruutu, P
[J]. BONE MARROW TRANSPLANTATION, 2001, 27 (01) : 79 - 84
[40] Parkkali T, 1996, BONE MARROW TRANSPL, V18, P961

← 1 2 3 4 5 6 →